Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)

Table 1 Patient characteristics

Characteristic	Data (n = 100)	Characteristic	Data (n = 100)
Age, y	Median, 59 (22–83)	EGFR mutation status
Sex		Wild	76
Female	20	Mutant	24
Male	80	Clinical T stage
Smoking		cT1	31
No	40	cT2	33
Yes	60	cT3	20
Pathology		cT4	16
Non-small cell carcinoma	12	Clinical N stage
Adenocarcinoma	49	cN0–1	7
Squamous cell carcinoma	39	cN2	53
Tumor diameter		cN3	40
≤3 cm	35	Sequence of CRT
> 3 cm, ≤5 cm	36	Concurrent	40
> 5 cm, ≤7 cm	19	Sequential	60
> 7 cm	10	Consolidation chemotherapy chemotherapy
Lung lobe		No	57
Upper and middle	74	Yes	43
Lower	26	Radiation Dose
Location		< 60 Gy	14
Central	41	≥60 Gy	86
Peripheral	59	Primary tumor volume (cm³)	Median, 45.19(0.89–392.9)
Clinical TNM stage		Lymph Nodal volume (cm³)	Median, 63.7(0–335.86)
cIIIA	36	Total volume (cm³)	Median, 140.0(19.79–481.28)
cIIIB	58
cIIIC	6

ISSN: 1748-717X